Relaxin Treatment in an Ang-II-Based Transgenic Preeclamptic-Rat Model

• Nadine Haase,

  Affiliation Experimental and Clinical Research Center, a joint cooperation between the Max Delbrück Center for Molecular Medicine in the Helmholtz and the Charité Medical Faculty, Berlin, Germany

  ⨯
• Michaela Golic,

  Affiliation Experimental and Clinical Research Center, a joint cooperation between the Max Delbrück Center for Molecular Medicine in the Helmholtz and the Charité Medical Faculty, Berlin, Germany

  ⨯
• Florian Herse,

  Affiliation Experimental and Clinical Research Center, a joint cooperation between the Max Delbrück Center for Molecular Medicine in the Helmholtz and the Charité Medical Faculty, Berlin, Germany

  ⨯
• Julianna Rugor,

  Affiliation Experimental and Clinical Research Center, a joint cooperation between the Max Delbrück Center for Molecular Medicine in the Helmholtz and the Charité Medical Faculty, Berlin, Germany

  ⨯
• Dominik Linz,

  Affiliation Klinik für Innere Medizin III, Kardiologie, Angiologie und Internistische Intensivmedizin, Universitätsklinikum des Saarlandes, Homburg/Saar, Germany

  ⨯
• Maria Emilia Solano,

  Affiliation Department of Obstetrics and Fetal Medicine, Laboratory for Experimental Feto-Maternal Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany

  ⨯
• Dominik N. Müller,

  Affiliation Experimental and Clinical Research Center, a joint cooperation between the Max Delbrück Center for Molecular Medicine in the Helmholtz and the Charité Medical Faculty, Berlin, Germany

  ⨯
• Ralf Dechend

  * E-mail: ralf.dechend@charite.de

  Affiliations Experimental and Clinical Research Center, a joint cooperation between the Max Delbrück Center for Molecular Medicine in the Helmholtz and the Charité Medical Faculty, Berlin, Germany, HELIOS-Klinikum Berlin, Berlin, Germany

  ⨯